Tuesday, February 26, 2019

SunTrust Banks Analysts Cut Earnings Estimates for Herbalife Nutrition Ltd (HLF)

Herbalife Nutrition Ltd (NYSE:HLF) – Equities researchers at SunTrust Banks dropped their Q1 2019 earnings estimates for Herbalife Nutrition in a note issued to investors on Wednesday, February 20th. SunTrust Banks analyst M. Swartz now anticipates that the company will earn $0.69 per share for the quarter, down from their previous estimate of $0.74. SunTrust Banks also issued estimates for Herbalife Nutrition’s Q2 2019 earnings at $0.89 EPS, Q3 2019 earnings at $0.83 EPS and Q4 2019 earnings at $0.79 EPS.

Get Herbalife Nutrition alerts:

A number of other analysts also recently commented on the company. Argus reiterated a “buy” rating and issued a $72.00 price objective on shares of Herbalife Nutrition in a research report on Friday, January 4th. Pivotal Research reiterated a “buy” rating and issued a $62.00 price objective (down previously from $75.00) on shares of Herbalife Nutrition in a research report on Wednesday, October 31st. Royal Bank of Canada reiterated a “hold” rating on shares of Herbalife Nutrition in a research report on Friday, November 9th. Tigress Financial reiterated a “buy” rating on shares of Herbalife Nutrition in a research report on Friday, November 16th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $65.00 price objective on shares of Herbalife Nutrition in a research report on Thursday, November 1st. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $62.36.

Shares of HLF stock opened at $56.13 on Thursday. Herbalife Nutrition has a 12 month low of $41.42 and a 12 month high of $61.77. The company has a market capitalization of $8.79 billion, a price-to-earnings ratio of 19.49, a PEG ratio of 1.01 and a beta of 0.37.

Herbalife Nutrition (NYSE:HLF) last announced its quarterly earnings data on Tuesday, February 19th. The company reported $0.63 EPS for the quarter, topping the Zacks’ consensus estimate of $0.61 by $0.02. Herbalife Nutrition had a negative return on equity of 71.82% and a net margin of 6.06%. The company had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.19 billion. During the same quarter last year, the company earned $1.29 EPS. The company’s quarterly revenue was up 8.5% on a year-over-year basis.

Several institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. raised its holdings in shares of Herbalife Nutrition by 1.0% in the 3rd quarter. Vanguard Group Inc. now owns 10,058,515 shares of the company’s stock worth $548,692,000 after buying an additional 103,973 shares in the last quarter. Vanguard Group Inc increased its stake in shares of Herbalife Nutrition by 1.0% in the 3rd quarter. Vanguard Group Inc now owns 10,058,515 shares of the company’s stock valued at $548,692,000 after buying an additional 103,973 shares during the period. FMR LLC boosted its position in shares of Herbalife Nutrition by 91.2% in the 2nd quarter. FMR LLC now owns 7,662,197 shares of the company’s stock worth $411,614,000 after purchasing an additional 3,654,763 shares during the last quarter. Renaissance Technologies LLC boosted its position in shares of Herbalife Nutrition by 42.1% in the 3rd quarter. Renaissance Technologies LLC now owns 7,601,225 shares of the company’s stock worth $414,647,000 after purchasing an additional 2,251,900 shares during the last quarter. Finally, BlackRock Inc. boosted its position in shares of Herbalife Nutrition by 3.4% in the 3rd quarter. BlackRock Inc. now owns 5,698,507 shares of the company’s stock worth $310,854,000 after purchasing an additional 188,790 shares during the last quarter. 89.34% of the stock is owned by institutional investors and hedge funds.

Herbalife Nutrition Company Profile

Herbalife Nutrition Ltd. develops and sells nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. It provides science-based products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition.

Further Reading: Cost of Goods Sold (COGS)

Earnings History and Estimates for Herbalife Nutrition (NYSE:HLF)

Saturday, February 23, 2019

Grand Canyon Education (LOPE) Q4 2018 Earnings Conference Call Transcript

Logo of jester cap with thought bubble with words 'Fool Transcripts' below it

Image source: The Motley Fool.

Grand Canyon Education (NASDAQ:LOPE) Q4 2018 Earnings Conference CallFeb. 20, 2019 4:30 p.m. ET

Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

Operator

Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Grand Canyon Education Incorporated fourth-quarter 2018 earnings conference call. [Operator instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to Mr.

Dan Bachus, chief financial officer. Please begin, sir.

Dan Bachus -- Chief Financial Officer

Thank you. Joining me on today's call is our Chairman and CEO Brian Mueller. Please note that many of our comments today will contain forward-looking statements that involve risks and uncertainties. Various factors could cause our actual results to be materially different from any future results expressed or implied by such statement.

These factors are discussed in our SEC filings, including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. We undertake no obligation to provide updates with regard to the forward-looking statements made during this call, and we recommend that all investors review these reports thoroughly before taking a financial position in GCE. And with that, I will turn the call over to Brian.

Brian Mueller -- Chairman and Chief Executive Officer

Good afternoon, and thank you and welcome to Grand Canyon Education's fourth-quarter fiscal-year 2018 conference call. During the fourth quarter of 2018, enrollment increased 7.8% to 97,400. New working adult students attending GCU online, grew in the low teens year over year, which exceeded expectations. I want to start by reviewing the size and scope of GCE services that they were delivered in the fourth quarter of 2018.

First, from the curriculum-development area, two new programs were released to the universities for implementation. I want to remind you that GCU is responsible to select all new programs, is responsible for the content and learning outcomes of those programs, sets the admissions requirements for students and the academic requirements for faculty teaching the program. The new programs were Bachelor of Science in Elementary Education, with an emphasis in STEM and a Master of Education in School Counseling. In addition, there were 11 programs and certificates that were revised or updated.

Second, from the faculty services area, there were six full-time and 245 adjunct faculty recruited and trained. There were also 100 additional sessions of faculty training and professional development. These examples of these trainings include boosting student success, the first-year experience, from theory to practice and creating collaborate classrooms. Third, in the admissions area, a total of 19,875 transcripts were evaluated, which provides prospective students the information they need in order to make a decision to start a program.

Fourth, in financial aid, 154,339 files were touched. Fifth, in the scheduling area, 19,631 classes were scheduled, with an average class size of 14.3. Sixth, our academic counselors performed 550,000 activities on behalf of students in the quarter, including activities such as welcome call to new students, course reminder calls, GPA concerns, attendance, finance changes, missing documents, practicum or licensure follow-up and schedules built or changed. Seventh, in technical support, 57.3% of the calls were answered with no hold time and if placed on hold, the average time was less than a minute and 26 seconds.

Eighth, our advertising work was very efficient in providing the necessary coverage to significantly exceed our enrollment goals. Ninth, we continued to enhance our technology platforms during the fourth quarter. We are currently working on over 80 software projects. We have successful pilot of our cloud-resource platform doing GCU's full term.

GCU has increased the use of platform, excuse me, during spring term when we are jointly modifying GCU curriculum to use the platform in additional IT, cybersecurity and programming courses going forward in both traditional and online course delivery. We continue to use our deep-analytic platform to improve student support. One key area we use this information is in automating the scheduling and tracking the field experience required in several of our programs, including education and counseling. GCE has invested over $200 million in advanced technologies, resulting in automated services and artificial intelligence to support students, faculty and counselors over the last 10 years.

I've reviewed just some of these. The objective going forward is to implement those capabilities over six core growth strategies. The goal is to work with partners to provide high-quality academic services, that will produce quality outcome metrics for the university and career opportunities for the students. The metrics include but are not limited to high graduation rates, low debt amounts and low default rates on student loans.

First, GCU's traditional ground campus will continue to grow, both in quantity and quality of the students. GCU's new nonprofit status has provided a tailwind from a new student growth perspective. In the fall of 2018, the ground campus produced a record 7,000 new students. Given the current flow of applications, registrations and deposits, for fall of 2019, we expect approximately 8,000 new students.

The average incoming GPAs will again be over 3.5 and the Honors College will grow to 2,400, with average incoming GPAs exceeding 4.1. The campus will grow to 30,000 students, with over 300 academic programs over the next five to seven years. Average revenue per student will continue to rise because the percent of all students living on campus will continue to go up. Second, the goal is to grow GCU's online campus at 6% to 7%.

However, the nonprofit status of the university has created a tailwind impact for online students as well. In the fourth quarter of 2018, new enrollments grew in the low teens, which is well above the goal. GCE will continue to support GCU's goal of growing the online campus with 60% of the students working on graduate degrees or RN to BSN degrees. This will enable the university to continue to produce quality metrics around graduation rates, loan amounts and default rates on student loans.

Third, GCE will support Orbis, as it grows its existing 18 locations, with its partners BSN licensure programs -- pre-licensure programs. Orbis will expand a number of locations through its partners by adding seven new locations in the 2019 calendar year. Orbis will continue to focus on the high-quality outcomes it has produced with its partners, including a 90% graduation rate and a 93% first-time pass rate on the NCLEX exams. Fourth, Orbis will use GCU's pre-licensure program to add a limited number of locations in certain western marketplaces, where it makes sense.

There are still over 70 markets in U.S., where Orbis can expand. Fifth, Orbis will work with its partners to expand the number of programs it offers in the healthcare area on its existing locations. Programs such as nurse practitioner, occupational therapist and physical therapy will eventually be added. There's going to be huge shortages of healthcare professionals in the next 10 years as the baby boom generation ages and requires increased levels of care.

Orbis has established an outstanding reputation for working with its University partners to produce high-quality outcomes. Sixth, GCE will continue to work with -- work to gain additional University partners. The goal is to find partners that want to combine the strength of their local or regional brand with GCE's capability to execute at a high level from an operational perspective. We continue to look for partners that are clearly differentiated based on geography, brand, programs, price point, etc.

We have walked away from several opportunities to date, because we haven't found the right amount of differentiation. In last quarter's call, I indicated we were considering five options. We've walked away from two of those, are continuing to have discussions with three and have entered into discussions with two additional entities. Now turning to the results of operations.

As a reminder, beginning July 1, 2018, the results of our operations do not include the university operations of GCU. It rather reflects the operations of GCE as a service-technology provider. Therefore, for comparability purposes, we will discuss amounts on an adjusted basis as is discussed in a minute. Service revenues were $177.5 million in the fourth quarter of 2018, compared to $271.4 million of university related revenue in the prior year.

Had the transaction occurred on July 1, 2017, comparable service fee revenue would have been $162.9 million in the fourth quarter of 2017. This represents an increase of 9% between fourth quarter of 2017 and fourth quarter of 2018 on a comparable basis. The increase year over year in comparable as adjusted revenue was due to an increase in GCU's enrollment and an increase in GCU's ancillary revenue, resulting from increased traditional student enrollment. Enrollment at GCU increased 7.8% between December 31, 2017, and December 31, 2018.

As adjusted operating income and as adjusted operating margin for the three months ended December 31, 2018, were $80.5 million and 45.3% respectively. As adjusted operating income, as adjusted operating margin for the three months ended December 31, 2017, were $69.7 million and 42.8% respectively. Technology and academic services grew from $10.7 million in the fourth quarter of 2017 to $11.1 million in the fourth quarter of 2018, an increase of $0.4 million or 3.3%. This increase was primarily due to increases in employee compensation and related expense compensation due to the increased number of staff needed to support our client, GCU and its increased enrollment, tenure-based salary adjustments and increased benefit cost between years.

As a percent of comparable revenue, these costs decreased 30 basis points to 6.3%, primarily due to our ability to leverage our technology in academic services personnel across an increasing revenue base, partially offset by the planned reinvestment of a portion of the savings provided by our lower tax rate in increased employee compensation and benefit cost. Counseling services and supports expenses grew from $50.2 million in the fourth quarter of 2017 to $52 million in the fourth quarter of 2018, an increase of $1.8 million or 3.5%. This increase is due to increased employee compensation and benefit cost between years, to service GCU and its enrollment. As a percentage of comparable revenue, these costs decreased 150 basis points to 29.3% from 30.8%, due primarily to our ability to leverage our counseling services and support expenses across an increasing revenue base, partially offset by the planned reinvestment of a portion of the savings provided by our lower tax rate in increased employee compensation and benefit costs.

Marketing and communication expenses as a percent of comparable revenue decreased 80 basis points from quarter 4, 2017 to quarter 4, 2018. General and administrative expenses increased $0.7 million between years and as a percentage of comparable revenue increased 10 basis points to 3.8% in quarter 4, 2018 from 3.7% in quarter 4 of 2017. This increase was primarily due to increases in employee compensation and benefit costs between years as our staffing increased to service GCU and its enrollment growth. With that, I would like to turn it over to Dan Bachus, our CFO, to give a little more color on our 2018 fourth quarter, talk about changes in the income statement, balance sheet and other items as well as to provide 2019 guidance.

Dan Bachus -- Chief Financial Officer

Thanks, Brian. Service revenues slightly exceeded our expectations in the fourth quarter of 2018, primarily due to GCU's higher enrollment and higher ancillary revenues. Revenue per student decreased as expected in the fourth quarter of 2018 compared to the prior year due to a shift in the timing of start dates for our clients' ground traditional students, resulting in one less revenue-producing day in the fourth quarter of 2018. GCU has not raised its tuition for its traditional ground programs in 10 years and tuition increases for working adult programs have averaged 1% or less.

Our effective tax rate for the fourth quarter of 2018 was 19.5%, compared to 25.5% in the fourth quarter of 2017. The lower effective tax rate year over year is a result of the Tax Cuts and Jobs Act, which was signed into law on December 22, 2017. The Act reduced the corporate federal tax rate from a maximum of 35% to a flat 21% rate effective January 1, 2018. The act also created the opportunity for GCE to submit method changes in conjunction with the filing of its 2017 federal tax return that resulted in a favorable impacted tax expense of approximately $1 million in the fourth quarter of 2018.

Our increased contributions made in lieu of state income taxes from $2 million in Q3 2017 to $3.7 million in Q3 2018, also helped reduce our effective tax rate. We receive a dollar-for-dollar state tax credit for these contributions, which are recorded in general and administrative expenses in the third quarter, 75% of these amounts are recorded as a reduction in the effective tax rate in the third quarter and 25% is recorded in the fourth quarter, as did the favorable impact from excess tax benefits of $2.6 million in quarter 4, 2018, compared to $1.1 million in quarter 4 of 2017. Given that the effective tax rate included in our fourth-quarter guidance was 21.7%, $0.05 of the earnings beat is due to the lower effective tax rate. We repurchased 52,784 shares of common stock in the fourth quarter of 2018 at a cost of approximately $5.5 million.

We had $88.1 million available under our share-repurchase authorization as of December 31, 2018. In January 2019, under previously executed 10b5-1 plan, we purchased an additional 107,527 shares of our common stock at a cost of approximately $10 million. Turning to the balance sheet and cash flows. Total unrestricted cash and short-term investments at December 31, 2018 were $120.3 million.

Restricted cash and cash equivalents were $61.7 million as of December 31, 2018 and represents the cash collateral on the credit agreement, which was released in January with the amended and restated credit agreement, which I will describe in a minute. GCE CAPEX in the fourth quarter of 2018 was approximately $4.4 million or 2.5% of net revenue. We estimate GCE's 2019 CAPEX, including Orbis should range between $20 million and $25 million, consisting primarily of software development and the build-out of Orbis partner locations. We anticipate funding CAPEX on behalf of GCU through the secured note of approximately $100 million in 2019.

This funding is to finish the 2018-'19 school year projects and three additional apartment-style residence halls and a parking garage for the 2019-'20 school year. Based on recent conversations with GCU, it's likely that the university will not request us to continue to fund its CAPEX after this year as the university anticipates they will be able to fund its own CAPEX moving forward. On January 22, 2019, in conjunction with the closing of the Orbis acquisition, GCE entered into an amended and restated credit agreement and two related amendments that, together, provide a credit facility of $325 million, comprised of a term-loan facility of $243.75 million and revolving credit facility of $81.25 million, both with a 5-year maturity date. The term facility is subject to quarterly amortization of principal commencing with the first quarter -- with the fiscal quarter ended June 30, 2019, in equal installments of 5% of the principal amount of the term facility per quarter.

Both the term loan and revolver have monthly interest payments currently at 30-day LIBOR, plus an applicable margin of 2%. The proceeds of the term loan, together with $6.25 million drawn under the revolver and cash on hand, were used to pay the purchase price of the acquisition. Concurrent with the acquisition and credit agreement, we repaid our $60 million in term debt and the cash collateral of $61.7 million was released. Last, I would like to provide color on guidance we have provided for 2019.

As you have probably noticed, we're again providing estimates for each quarter of 2019. We do this because our financial results including GCU and the universities that Orbis services are seasonal. The guidance that we have provided includes Orbis financial result with the exception of intangible-asset amortization, transaction costs associated with the acquisition and the tax impact for those items. We plan to provide a non-GAAP as adjusted net income beginning with the first quarter of 2019 that reconciles as reported GAAP net income to as adjusted non-GAAP net income to reflect these adjustments.

Although, the intangible asset valuation is not yet finalized, we estimate that annual book intangible asset amortization expense will be approximately $11 million and we anticipate transaction costs recorded in the first quarter of 2019 to be approximately $5 million. Our enrollment guidance assumes high single-digit GCU online new start growth. Our guidance assumes an increase in GCU graduates between years of approximately 13%. The significant retention gains and accelerated start growth GCU has experienced in recent years continues to result in year-over-year increases in graduates that exceed its total enrollment growth rate.

As we have discussed previously, enrollment growth rates for GCU ground students are impacted by a high percentage of its students are graduating in less than four years. We anticipate that GCU revenue per student will continue to grow year over year as a result of the growth of GCU's ground traditional student. GCU revenue per student will be impacted by changes between 2018 and 2019, when the traditional campus semesters begin and end and when online breaks occur. The spring, summer and fall semesters start one day earlier in 2019 than in 2018, pushing revenue from Q2 to Q1 from Q3 to Q2 and from Q4 to Q3.

The 2018 Christmas break had a net impact of pushing one day of revenue from 2018 to 2019 and the 2019 Christmas break has a net impact of pushing one day of revenue from 2019 to 2020. We estimate the effect of these changes are $900,000 of more revenue in quarter 1, $600,000 of less revenue in quarter 2, $700,000 of more revenue in quarter 3 and $1.1 million of less revenue in quarter 4. The net loss of revenue about $100,000 is related to the timing of the online Christmas breaks. We estimate the Orbis revenue will be approximately $87.7 million 2019, which represents a 40.3% growth over its 2018 revenue of $62.5 million.

Given that the close of the transaction occurred on January 22, 2019, $3.7 million of this revenue will not be recognized in our financials. Total enrollment will be approximately 101,900 at March 31, 91,000 at June 30, 109,400 at September 30 and 108,000 at December 31, with Orbis enrollment being approximately 3,200 at March 31, 3,300 at June 30, 3,800 at June -- at September 30 and 3,800 at December 31 of those amounts. On the expense side, we anticipate the core GCE business to see increased margins of 30 basis points year over year, excluding $2 million of fees incurred in Q1 2019, related to a discreet tax item that will have the effect of lowering our quarter 1, 2019 effective tax rate. This item is included in the guidance provided.

Orbis will be approximately breakeven from an EBIT standpoint, excluding the intangible asset amortization and transaction cost. We anticipate technology and academic services, counseling services and support, marketing and communications and general administrative expense will be approximately 11%, 29.8%, 18.5% and 6.1% of net revenues respectively, and thus consolidated operating margin will be 34.6% of net revenues. We estimate interest income on the note from GCU will be approximately $58.2 million as the note continues to grow over the course of 2019, as GCE funds GCU's CAPEX. We estimate interest expense will be approximately $10.5 million, declining slightly over the course of the year due to principal pay downs and that other interest income will be approximately $2.3 million, a substantial portion of which will be in Q1, 2019.

Our guidance this year assumes an effective tax rate, excluding contributions made in lieu of state income taxes to be 17.3% in Q1, 24.5% in Q2, 24.6% in Q3 and 24.1% in Q4. The lower rate in Q1 is due to the majority of restricted stock vesting occurring in that quarter each year and the decrease from the prior year is due to the discreet tax item I mentioned earlier. The year-over-year increase in the effective tax rate especially in the fourth quarter is due to higher estimated state income tax as a result of the transaction, the one-time method change benefit received in the fourth quarter of 2018 and due to the contributions in lieu of state income taxes not being factored into our guidance. If a contribution in lieu of state income taxes is made in the third quarter of 2019, it will have the effect of the increasing general and administrative expenses and decreasing income-tax expense.

Although, we might repurchase additional shares during 2019, these estimates do not assume repurchases other than those made in the first quarter. I will now turn the call back over to Brian to share a few final thoughts.

Brian Mueller -- Chairman and Chief Executive Officer

In this conference call, we have referred to three organizations: Grand Canyon Education, Orbis and Grand Canyon University. Prior to the recent transaction, Grand Canyon University and what is now Grand Canyon Education was a single entity. We operated as a single entity for 10 years and during that time, developed a culture or ethos that came to define us. Our goal was to make private Christian higher education affordable for all socioeconomic classes of Americans.

Using the public market to get access to capital and building a hybrid campus consisting of traditional students on our campus and nontraditional students online, leveraging a common infrastructure created huge efficiencies. The greater or common good was clearly being served. We were able to grow to 97,000 students, invest over $1.2 billion in educational infrastructure and not raise tuition in 10 years on a traditional campus with less than 1% increases in the online campus. This has led to huge diversity on the campus, with 28% of our students being Hispanic, 7% African-American and over 40% students of color.

Again, the greater or common good being served. Grand Canyon University is now a nonprofit institution, with its own board and mission. Grand Canyon Education is now an educational services company, with its own board and mission. There is no overlap from a broad perspective.

However, the culture or ethos of the greater or common good lives on in both organizations. This can best be witnessed in a continued commitment from both organizations to transform into inner-city neighborhood, where we both reside. Our now joint five-point plan continues to make amazing progress. We have created 10,700 jobs between the two organizations and another 400 jobs through eight new businesses.

Our partnerships in investment with the City of Phoenix police has crime dropping in the neighborhood. Our Habitat program has improved over 220 homes and housing values are up over 50% since we started the program. We now have over 1,200 students providing tutoring to over 100 local schools between 3:00 and 8:00 p.m. Monday through Friday, and 10:00 a.m.

to 6:00 p.m. on Saturday. In addition, there are dozens of student-led projects going on in the neighborhood on a daily basis to support disadvantaged populations and drive increased levels of prosperity. We like the business model at Orbis but also like their culture or ethos.

They are serving a greater or common good, as they create a win-win relationship with healthcare providers and universities in order to service students and communities in a very unique way. Orbis will continue to move forward with the full support and resource of Grand Canyon Education. Grand Canyon Education will continue to look for partners to create win-win situations that are sound and productive from a business perspective for both parties, but also always serve the greater or common good. I will now turn the call over to the moderator so we can answer questions. 

Questions and Answers:

Operator

[Operator instructions] Our first question or comment comes from the line of Peter Appert from Piper Jaffray. Your line is open.

Peter Appert -- Piper Jaffray -- Analyst

Thanks. Good afternoon. So Brian, based on your comments, based on the guidance, definitely feels like you're seeing a tailwind in terms of the enrollment growth numbers from the conversion. Do you have a new target in terms of what you think would be a reasonable growth rate going forward for the online business in particular?

Brian Mueller -- Chairman and Chief Executive Officer

Well, we knew that would be the first question. We still say 6% to 7% from an online standpoint. There definitely was a tailwind. We had a very strong fourth quarter, especially in terms of new starts.

We're off to a good start in the fourth -- in the first quarter. The question is how long will that last? And so we're going to be conservative like we always are. We'll try to under-promise and over-deliver. So yes, low teens, new students online growth was more than we expected.

And I think, it's evidence that being out there now a million times a day saying we're nonprofit has had an impact. We've had our competitors tell us openly. We bullied you guys every single day for 10 years with the fact that you shouldn't go to a for-profit institution. We grew in spite of that and now we are benefiting from that nonprofit status even though tuition levels haven't changed, etc.

But increasing our goals in the short run, we're not ready to do that yet.

Peter Appert -- Piper Jaffray -- Analyst

OK, fair enough. And then on the Orbis business, the growth -- enrollment growth numbers, Dan, that you gave, would that assume any new university clients? And then, sort of related to this, you've mentioned breakeven from an EBIT perspective. Any thoughts in terms of the longer-term financial model for Orbis?

Dan Bachus -- Chief Financial Officer

Yes, so that does include, as Brian said on the call, seven additional locations opening in 2019. Those partners have already been signed-up locations, have already all been determined and they will open at different times over the course of the year. They obviously, continue to work on additional partners and additional locations for 2020 and going forward but a lot of those locations and partners have already been determined for 2020 and going forward.

Brian Mueller -- Chairman and Chief Executive Officer

So the new locations in 2019 do not need additional university partners. They're going to be done with the current partners.

Peter Appert -- Piper Jaffray -- Analyst

Right. Exactly. OK. And then...

Dan Bachus -- Chief Financial Officer

In terms of margins, as we've talked about before, the EBIT is basically breakeven, which is actually slightly better than what we had thought going into the year but as they've completed their budget process that's where they got to. The margin profile of the business as a whole is highly dependent on the number of new locations that are opened during the year in comparison to the number of existing or more mature locations. And so as the percentage of new locations, as a percentage of the total number of locations decreases over time, you will see Orbis be profitable.

Peter Appert -- Piper Jaffray -- Analyst

OK. And then, last thing, Brian, in terms of the discussions with new potential OPM clients, it sounds like you're being obviously, very thoughtful in this process, which might imply that it's still a ways off in terms of signing that first client. Is that how we should think about it?

Brian Mueller -- Chairman and Chief Executive Officer

We don't have anything to announce in the next 30 to 60 days. Although, you're right, the first -- we are being very careful. This Orbis purchase for us gave us a lot to do and it's a big -- it's just -- it fits so nicely into how we feel about the future of higher education, that getting behind them and supporting them is become a big priority now. It doesn't mean we're not looking for new partners, because we are.

We've got something that we're fairly excited about that will -- we think could be very, very successful. But yes, I would say not in next 30 to 60 days.

Peter Appert -- Piper Jaffray -- Analyst

OK, great. Thank you.

Operator

Thank you. Our next question or comment comes from the line of Jeff Meuler from Baird. Your line is open.

Jeff Meuler -- Baird -- Analyst

Yeah, thank you. Just on the guidance. Dan, you gave us a ton of detail but you ran through some of it pretty quick. Just on Orbis, I think, you're saying EBIT breakeven, excluding amortization expense, which is going to be excluded from adjusted EPS.

And then we'll have to layer on, I guess, the incremental interest expense, but then there's some tax savings. I guess, just -- can you net it all out for us? Like what is the EPS impact under the new adjusted EPS methodology for 2019 in terms of the Orbis impact?

Dan Bachus -- Chief Financial Officer

So the guidance we gave includes the interest expense -- higher interest expense associated with the purchase. So that's included in the guidance. The effective tax rate does not assume the tax deduction associated with the amortization of the intangible asset, because that actually turns out to be a temporary item not a permanent item, because we'll have book amortization of that asset. So the plan is to carve out in the adjusted EPS number, to carve out the intangible asset amortization along with the tax benefit of that intangible asset amortization as well as the transaction expenses.

But everything else associated with the Orbis is in the guidance that we've given, including the higher interest rate.

Jeff Meuler -- Baird -- Analyst

Enrolling that all together, it is dilutive and that's fully embedded in this $5.10 EPS figure. I didn't have it in my numbers, I don't think some of the others that they could incorporate it in consensus had it in, so I'm just trying to I guess make things as apples for apples as possible.

Dan Bachus -- Chief Financial Officer

Yeah, I think, what we try to do is give guidance that would be in line with that as adjusted EPS number that we'll give, similar to if you're all familiar with Strayer and the Capella acquisition, we'll do something similar to that. And so the things that are carved out will be the intangible asset amortization, along with the tax impact of that and the transaction cost. Everything else is embedded in the guidance that we gave, including the higher interest expense.

Jeff Meuler -- Baird -- Analyst

Got it. And then just to follow up to Peter's question on the school services or OPM clients for GCE as opposed to Orbis. Just if and when you eventually sign a client, is there -- the initial I would imagine there's initial expense that runs ahead of revenues. So is that the case? Is there initial dilution when you are first ramping a client? Any way to size up what you think that would be or the time lag to get that client to free cash flow or adjusted EBIT profitable? And then, are you embedding anything in the 2019 guidance for potential additional client signing?

Dan Bachus -- Chief Financial Officer

No, we haven't embedded anything in either the revenue or the expense guidance associated with the new GCE client. The reason, frankly, is it's going to be highly dependent on which client we sign and how aggressive that client wants to ramp-up. So if it's a client that wants to take a slow ramp, it'll have a smaller upfront expense impact, but the revenue obviously, will ramp slower than if it's a client that wants to ramp up at a faster rate. So until we have that client signed and know what -- how fast they want to ramp up, we just can't even size that upfront loss and then the revenue impact.

Jeff Meuler -- Baird -- Analyst

OK. And then just finally to the extent to which to improved marketing efficiency persists and it's a new normal. How do you think about reinvestment, flow-through? I guess what I'm wondering if each marketing dollar is more efficient, do you spend even more on marketing to drive even more enrollment? Or at some point, do you just start to stretch your operational capabilities if you're running at a teens rate or north of that?

Brian Mueller -- Chairman and Chief Executive Officer

Well, the answer to that is continue to build the quality of the students. And so if what's currently happening continues to happen and it happens for a while with the same quality of students, producing the high-graduation rates, the low-default rates and all of that, then we'll continue to invest at the current rate, which means we would have additional dollars to invest. And that would be perfect in terms of us being able to go into a relationship with another client. Another way to talk about this new GCE client thing, is the discussions that we're having, it becomes very apparent to people, because they tip their toe a little bit into online-delivered education.

They know they can't do to it. But they also know the power of their brand locally. And when they get accustomed to what our ability to operationalize something is as compared to theirs, they get excited about combining the two things and we do too. We've talked about the Northeast for example, where our brand has the least amount of visibility.

If you combine -- I say to people all the time, how does Grand Canyon University have any students in New Jersey for example? Well, it's very simple, a teacher calls a local university and they might get a call back in 30 days and maybe something happens with financial aid in 60 to 90 days. They get frustrated. They see our ad, they call Grand Canyon and within 72 hours, everything is done. Application is filled out, transcripts are evaluated, three different schedules are built, the financial aid is done.

They go to our website, they see Grand Canyon University, who it is and they say, OK, this just sounds good and they start. That's why we have students in the Northeast. What we're trying to convince people, obviously, if you take our ability to execute and combine it with the brand and sometimes three times the price point of one of those private universities, if you would have something that could be extremely productive and profitable for both groups. We just don't want to do that with four or five institutions in the Northeast, we'd like to do it with one, maybe two.

And so that's kind of -- those are the kind of the discussions that are evolving. And we think, based upon the direction things are going now, we're going to find one or two really good partners. And GCU's accelerated growth rate in the short term will produce revenues that allow us to get involved in some way and minimize the negative impact in the short run from a margin standpoint.

Jeff Meuler -- Baird -- Analyst

Excellent. Thanks and look forward to seeing you guys, tomorrow.

Brian Mueller -- Chairman and Chief Executive Officer

OK, thank you.

Operator

Thank you. Our next question or comment comes from the line of Jeff Silber from BMO Capital Markets. Your line is open.

Jeff Silber -- BMO Capital Markets -- Analyst

Thanks. Just to focus a little bit more on your potential partnerships with new university. You mentioned you walked away from a couple -- I'm not asking for proprietary information. But at a high level, I'm just curious what drove that decision to walk away?

Brian Mueller -- Chairman and Chief Executive Officer

Well, we -- without giving specific names, we had this state university in the West that was really interested in. And we had talks and we were getting down to the -- they really wanted to be a partner of ours and we really wanted to be their partner. But as we got down to the nitty-gritty of modeling it out, it just became apparent that at the price point of that state University system, with them having programs so similar to ours, both having brands pretty visible in the West, there wasn't going to be enough differentiation to make it worth our while. It was -- there would have been just too much cannibalization there.

And it wouldn't make sense. And so that is really what happened with the two that we walked away from. So in our minds, geographic differentiation, branding differentiation, price point, those are all things that if we can find the right place and those things all work together, it will be an optimal partner. And rather than sign three or four suboptimal partners, we'd rather sign one or two optimal partners, where all those things are working.

And we've got lots of data on the Northeast and the Southeast and what we convert leads at and what price point we can charge versus what our competition is charging. And so we're being careful. And we'll get there, we will get there. We'll get there with the right people.

But in addition to that, and I can't tell you how excited we are about this Orbis thing. They've got a really, really good business. And it's got tremendous scale potential and the class that -- the path to profitability is very clear. And so we'll continue with university of -- with Grand Canyon University.

We'll continue with Orbis and we'll eventually find the right one or two partners that can really enhance Grand Canyon Education.

Jeff Silber -- BMO Capital Markets -- Analyst

OK, that's great. And I don't mean to deflect attention away from Orbis. I know we're going to be hearing a lot about it tomorrow evening. But just to go back to the other university partners.

And again, I'm not asking for proprietary information, but at a high level are you approaching them with the revenue share agreement similar to what you have at Grand Canyon University? Is it more of a fee for service? Or are you flexible on either pricing model?

Brian Mueller -- Chairman and Chief Executive Officer

We're doing the same. We're approaching them with the same model that we have here. Although, I will tell you that we've got one program that is a little bit different than -- and one that we're -- will come out of left field and we're very excited about. We'll see if it happens.

I can't give you any more detail on that. Hopefully, in 30 to 60 days, I will be...

Dan Bachus -- Chief Financial Officer

I think, Jeff, we're flexible. I mean, our preference will be a revenue share similar to GCU but that doesn't mean we wouldn't do a cost-plus or some other type of arrangement.

Jeff Silber -- BMO Capital Markets -- Analyst

Got it. And I just got one more follow-up on the guidance. And forgive me I can read this about in the transcript, but did you say that if we take out the Orbis impact on your guidance that the pure business itself, you're looking at about 30 basis points in margin expansion in 2019? Is that what I heard?

Dan Bachus -- Chief Financial Officer

Yeah, that's correct. The guidance includes 30 basis points of margin expansion for the core GCE business.

Jeff Silber -- BMO Capital Markets -- Analyst

All right, perfect. Thanks so much.

Dan Bachus -- Chief Financial Officer

We have reached the end of our fourth-quarter conference call. We appreciate your time and interest in Grand Canyon Education. If you still have questions, please contact myself, Dan Bachus. Thank you very much for your time.

Operator

[Operator sign-off]

Duration: 44 minutes

Call Participants:

Dan Bachus -- Chief Financial Officer

Brian Mueller -- Chairman and Chief Executive Officer

Peter Appert -- Piper Jaffray -- Analyst

Jeff Meuler -- Baird -- Analyst

Jeff Silber -- BMO Capital Markets -- Analyst

More LOPE analysis

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

10 stocks we like better than Grand Canyon EducationWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Grand Canyon Education wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of January 31, 2019

Friday, February 22, 2019

Top Growth Stocks To Invest In Right Now

tags:JWN,ISRG,BWLD,TBI,MED,

Analysts forecast that Monster Beverage Corp (NASDAQ:MNST) will announce sales of $991.58 million for the current fiscal quarter, Zacks reports. Six analysts have issued estimates for Monster Beverage’s earnings, with the highest sales estimate coming in at $1.01 billion and the lowest estimate coming in at $984.60 million. Monster Beverage posted sales of $909.48 million during the same quarter last year, which would indicate a positive year over year growth rate of 9%. The business is expected to announce its next quarterly earnings results on Wednesday, November 14th.

On average, analysts expect that Monster Beverage will report full-year sales of $3.76 billion for the current financial year, with estimates ranging from $3.74 billion to $3.78 billion. For the next year, analysts anticipate that the firm will report sales of $4.16 billion per share, with estimates ranging from $4.09 billion to $4.29 billion. Zacks’ sales averages are a mean average based on a survey of analysts that cover Monster Beverage.

Top Growth Stocks To Invest In Right Now: Nordstrom Inc.(JWN)

Advisors' Opinion:
  • [By ]

    Cramer and the AAP team are sharing a positive research note on Norstrom (JWN) , and their analysis. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS. 

  • [By Motley Fool Transcription]

    Nordstrom, Inc. (NYSE:JWN) Q2 2018 Earnings Conference Call August 16, 2018, 4:45 p.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

  • [By Mac Greer]

    They have a lot of things in the works. They're kind of throwing some things at the wall and seeing what will stick. They have their Macy's Backstage concept, which is their discount concept. Every retailer has to have one nowadays, like a Nordstrom (NYSE:JWN) Rack, for example. They actually bought a concept store in New York City called Story, which is a store that revamps its inventory every four to eight weeks to try to keep it fresh. That would be some Inventory management job. Their buyers have their work cut out for them. But, interesting. They're trying a lot of different things. 

  • [By Dan Caplinger]

    Nordstrom (NYSE:JWN) has suffered along with much of the rest of the retail industry for quite a while now, as changes in the ways shoppers like to shop have forced companies across the sector to adapt their business practices and adopt new technologies. Some had hoped that the upscale Seattle-based retailer would prove immune to those trends, but Nordstrom hasn't escaped the resulting downward pressure. Now that it seems unlikely that the Nordstrom family will succeed in pulling off a leveraged buyout of the retailer, shareholders want to feel more confident about the future direction the company will take, especially as competitors have started to show signs of a recovery.

  • [By Jeremy Bowman]

    While Stitch Fix's styling service separates it from most apparel retailers online and off, it's not the only company using that model. There are dozens of other similar styling services out there including Trunk Club, now owned by Nordstrom (NYSE:JWN), Bombfell, Rent the Runway, and Le Tote. Some offer different hooks to draw in new customers, but almost all promise the same value proposition, clothing selected for you by personal stylists.

  • [By Motley Fool Staff]

    Nordstrom, Inc. (NYSE:JWN)Q1 2018 Earnings Conference CallMay 17, 2017, 4:45 p.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

Top Growth Stocks To Invest In Right Now: Intuitive Surgical Inc.(ISRG)

Advisors' Opinion:
  • [By Danny Vena]

    Robotic surgery pioneer Intuitive Surgical (NASDAQ:ISRG) has been a big winner, up 38% since the beginning of the year. Two companies that haven't been so fortunate are footwear maker Skechers (NYSE:SKX) and flooring retailer Tile Shop Holdings (NASDAQ:TTS), which have fallen 18% and 13% year to date, respectively. Here are some key metrics to watch when these companies report earnings in July.

  • [By Brian Feroldi]

    Medical device makers were some of the best-performing companies on the market last year. In this week's episode of Industry Focus: Healthcare, host Shannon Jones and Motley Fool contributor Brian Feroldi talk about three medical device monopolies that investors might want to take a closer look at. Listen and find out what makes Intuitive Surgical (NASDAQ:ISRG), Abiomed (NASDAQ:ABMD), and NovoCure (NASDAQ:NVCR) stand out from the crowd, dominate their niches, and improve patient lives. Plus, learn the key metrics investors should watch, what long-term risks to be aware of, which of the companies faces the most competitive risk, some of the most exciting opportunities still ahead, and more.

  • [By Motley Fool Transcribing]

    Intuitive Surgical (NASDAQ:ISRG) Q4 2018 Earnings Conference CallJan. 24, 2019 4:30 p.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

  • [By Brian Feroldi]

    Medtronic (NYSE:MDT) and Intuitive Surgical (NASDAQ:ISRG) are two of the most successful medical device companies of all time.

    Medtronic has been hawking medical devices since it was founded in 1949, and it has been a stellar long-term investment. The company has turned into such a steady-eddy business that it has raised its dividend for 41 years in a row.

Top Growth Stocks To Invest In Right Now: Buffalo Wild Wings Inc.(BWLD)

Advisors' Opinion:
  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen's clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby's Restaurant Group:

  • [By Steve Symington]

    That's not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.

Top Growth Stocks To Invest In Right Now: TrueBlue Inc.(TBI)

Advisors' Opinion:
  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Trueblue (TBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    TrueBlue Inc  (NYSE:TBI)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:00 p.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Media stories about Trueblue (NYSE:TBI) have trended somewhat positive on Monday, according to Accern Sentiment. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Trueblue earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media stories about the business services provider an impact score of 45.3296498009881 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

  • [By Stephan Byrd]

    American Century Companies Inc. grew its holdings in shares of Trueblue Inc (NYSE:TBI) by 24.4% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 95,307 shares of the business services provider’s stock after purchasing an additional 18,680 shares during the period. American Century Companies Inc. owned approximately 0.23% of Trueblue worth $2,468,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Trueblue Inc (NYSE:TBI) by 18.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,550 shares of the business services provider’s stock after purchasing an additional 4,700 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Trueblue were worth $823,000 as of its most recent filing with the Securities & Exchange Commission.

Top Growth Stocks To Invest In Right Now: MEDIFAST INC(MED)

Advisors' Opinion:
  • [By Ethan Ryder]

    MediBloc [MED] (CURRENCY:MED) traded down 11.7% against the U.S. dollar during the 1 day period ending at 21:00 PM Eastern on September 2nd. One MediBloc [MED] token can now be bought for approximately $0.0066 or 0.00000100 BTC on popular cryptocurrency exchanges including Coinrail, Bibox and Gate.io. During the last week, MediBloc [MED] has traded down 27.6% against the U.S. dollar. MediBloc [MED] has a total market cap of $19.63 million and approximately $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours.

  • [By Sean Williams]

    Meanwhile, Medifast's (NYSE:MED) share price has tripled since the beginning of March. Medifast's second-quarter operating results showcased a 55% increase in sales and an 84% improvement in year-over-year adjusted earnings per share. A substantial increase in Optavia-branded products sold, along with a big jump in active earning coaches, drove results. The company also substantially lifted its full-year sales and profit guidance (close to 20% at the midpoint for both measures). 

  • [By Lisa Levin] Gainers Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares jumped 29.86 percent to close at $2.87 on Friday. Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares gained 28.87 percent to close at $8.75 after reporting upbeat Q1 earnings. Mexco Energy Corporation (NYSE: MXC) gained 27.02 percent to close at $5.4744. Carbon Black, Inc. (NASDAQ: CBLK) climbed 26 percent to close at $23.94. Carbon Black priced its IPO at $19 per share. Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 25.64 percent to close at $42.44 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban. Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.19 percent to close at $8.50 after reporting Q2 results. California Resources Corporation (NYSE: CRC) shares gained 22.45 percent to close at $31.58 following upbeat Q1 earnings. Atomera Incorporated (NASDAQ: ATOM) gained 22.31 percent to close at $6.25 after reporting Q1 results. Medifast, Inc. (NYSE: MED) shares jumped 22.27 percent to close at $121.46 after the company reported strong Q1 results and raised its FY18 guidance. Jerash Holdings (US), Inc. (NASDAQ: JRSH) gained 20.86 percent to close at $8.46. Pandora Media, Inc. (NYSE: P) rose 19.83 percent to close at $6.89 after reporting strong quarterly results. Shake Shack Inc (NYSE: SHAK) rose 18.01 percent to close at $55.95 on Friday after the company reported upbeat results for its first quarter and raised its FY18 guidance. Super Micro Computer, Inc. (NASDAQ: SMCI) rose 17.73 percent to close at $21.25 after reporting strong preliminary results for the third quarter. Schmitt Industries, Inc. (NASDAQ: SMIT) rose 17.41 percent to close at $2.36. Titan International, Inc. (NYSE: TWI) shares gained 16.78 percent to close at $12.25 following Q1 earnings. Integer Holdings Corporation (NYSE: ITGR) shares rose 14.23 percent to close at $63.40 following Q1 result
  • [By Lisa Levin] Gainers Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares rose 35.8 percent to $3.00. Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares surged 32 percent to $8.94 after reporting upbeat Q1 earnings. Carbon Black, Inc. (NASDAQ: CBLK) gained 29.6 percent to $24.62. Carbon Black priced its IPO at $19 per share. California Resources Corporation (NYSE: CRC) shares rose 26.8 percent to $32.70 following upbeat Q1 earnings. Pandora Media, Inc. (NYSE: P) gained 25 percent to $7.185 after reporting strong quarterly results. Medifast, Inc. (NYSE: MED) shares climbed 23.7 percent to $122.87 after the company reported strong Q1 results and raised its FY18 guidance. Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.2 percent to $8.4999 after reporting Q2 results. Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) gained 22.2 percent to $41.27 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban. Shake Shack Inc (NYSE: SHAK) rose 22.2 percent to $57.955 after the company reported upbeat results for its first quarter and raised its FY18 guidance. Atomera Incorporated (NASDAQ: ATOM) jumped 19.7 percent to $6.12 after reporting Q1 results. Super Micro Computer, Inc. (NASDAQ: SMCI) rose 16.4 percent to $21.00 after reporting strong preliminary results for the third quarter. Titan International, Inc. (NYSE: TWI) shares rose 16.4 percent to $12.21 following Q1 earnings. Integer Holdings Corporation (NYSE: ITGR) shares gained 14.9 percent to $63.75 following Q1 results. Control4 Corporation (NASDAQ: CTRL) shares climbed 14.5 percent to $23.98 folloiwng strong Q1 results. B&G Foods, Inc. (NYSE: BGS) climbed 12.6 percent to $25.40 after reporting Q1 earnings. HMS Holdings Corp (NASDAQ: HMSY) shares gained 10 percent to $19.59 after reporting upbeat quarterly earnings. Viavi Solutions Inc. (NASDAQ: VIAV) rose 7 percent to $10.09 following Q3 r

Wednesday, February 20, 2019

Aurora Cannabis and Canopy Growth Earnings Updates: What to Love and What to Loathe

The results are in: Two of the biggest Canadian marijuana producers, Aurora Cannabis (NYSE:ACB) and Canopy Growth (NYSE:CGC), reported earnings results last week. Those results were arguably the most important ever for the two companies since they were the first to include sales of recreational marijuana in Canada.

Judging by how the two marijuana stocks performed following their updates, Canopy Growth appeared to be the clear winner. However, both Aurora and Canopy reported some very good news and some not so good. Here's what investors can love -- and loathe -- about the big marijuana producers' latest earnings updates. 

Marijuana buds arranged to make a heart shape

Image source: Getty Images.

Love

Skyrocketing sales has to be at the top of the list for investors to love. Aurora reported net revenue of 54.2 million in Canadian dollars, up 363% year over year and 83% quarter over quarter. Canopy Growth announced net revenue totaling CA$83 million, an increase of 283% over the prior-year period and 256% over the previous quarter. 

As expected, most of the sales growth for both Aurora Cannabis and Canopy Growth came from the recreational marijuana market in Canada. Aurora's recreational sales for the quarter ending Dec. 31, 2018, were CA$21.6 million compared to CA$71.6 million for Canopy.

Canopy Growth claims a strong position right out of the gate in the Canadian recreational marijuana market, something investors can definitely love. When all of the top Canadian marijuana producers have reported their results, Aurora should be in a solid second place, which is at least worthy of being liked by investors, if not loved.

The primary reason why Aurora and Canopy are in their respective positions is another factor that should warm the hearts of investors. What is that reason? Solid production capacity.

Aurora currently has an annualized production run rate of 120,000 kilograms. The company's funded capacity totals 4.6 million square feet, or greater than 500,000 kilograms per year. Canopy Growth doesn't talk about its capacity in terms of kilograms per year, but the company already operates 10 licensed facilities with over 4.3 million square feet of production capacity. 

Loathe

The obvious thing to loathe about Aurora Cannabis' latest results was the company's big net loss of CA$237.8 million. Granted, Aurora's bottom line was negatively impacted by adjustments on the company's derivative investments totaling CA$190 million. However, the loss was ugly no matter how you look at it.

On the surface, Canopy Growth's earnings of CA$74.9 million might seem like something for investors to celebrate. There was more to the story, though. Canopy actually had an operating loss of CA$157.2 million. Its recorded earnings stemmed from fair value gains resulting from a declining value for its senior convertible notes.

Canopy's share price fell 45% in the quarter ending Dec. 31, 2018, weighing on the value of its convertible notes. Any paper profits that resulted primarily from that kind of dismal stock performance certainly is something for investors to loathe.

Neither Aurora Cannabis nor Canopy Growth can justify their current market caps based on the Canadian opportunity alone. Both companies must achieve significant growth in global marijuana markets to avoid a collapse in their share prices. But international sales represented 6% of total cannabis revenue for Aurora and only 3.3% of net revenue for Canopy. 

Admittedly, Aurora and Canopy are ahead of most of their peers in their international efforts. However, international sales remain very low for both of these marijuana producers. Loathe might be too strong of a word, but there's not much for investors to like yet about international sales for either Aurora Cannabis or Canopy Growth. 

And what to look for ahead

Quarterly results only provide a snapshot of what's happened in the past. But companies' updates also give a hint at what could be coming in the future. Investors have a lot of great things to look forward to with both Aurora Cannabis and Canopy Growth.

Revenue for Aurora and Canopy should continue to soar this year. Remember, the latest results for the companies didn't include a full quarter of recreational sales since the Canadian market opened on Oct. 17, 2018, two and a half weeks into the quarter. There were also some wrinkles in the early days of the recreational market that should be ironed out over time.

The anticipated launch of the market for cannabis edibles, beverages, and concentrates later this year should also provide a big revenue boost for both Aurora and Canopy. Aurora Cannabis CEO Terry Booth said that his company plans to be a first mover in getting new products on the market when it's legal to do so. Canopy Growth co-CEO Bruce Linton stated in his company's quarterly conference call that when it comes to cannabis edibles and beverages, "If it's legal, we'll have it."

Expect improving bottom lines for both Aurora Cannabis and Canopy Growth as well. Aurora's management noted that the one-time costs related to complying with packaging requirements for the recreational market won't be a factor in the future. The company's expenses connected with ramping up capacity at its Aurora Sky facility will also go away. Canopy expects gross margins to improve as its facilities reach full utilization. And both companies should see favorable product mix shifts to high-profit products like softgels.

Probably the most important thing to look for, though, is increased international momentum. Both Aurora and Canopy have laid the groundwork for capitalizing on growth in international marijuana markets. Success on this front would give something for investors to really love.

Tuesday, February 19, 2019

Top 5 Stocks To Buy For 2019

tags:ABTX,NTK,EGY,CYAD,KMG,

Yesterday, small cap security stock Patriot One Technologies (OTCQB: PTOTF; TSE: PAT.V) announced that its award-winning PATSCAN CMR™ (Cognitive Microwave Radar) concealed weapons detection system had received Industry Canada (IC) certification for commercial use in Canada with initial deployments to be undertaken in collaboration with law enforcement and government agency personnel at several strategic locations. However and due to the operational and sensitive nature of their activities, the law enforcement organization names and installation locations are withheld under non-disclosure agreements. The planned deployment of the PATSCAN CMR by these organizations is currently for internal, non-public use, and will focus on physical installation processes, fine tuning weapons profiles and ongoing software validation studies.

Top 5 Stocks To Buy For 2019: Allegiance Bancshares, Inc.(ABTX)

Advisors' Opinion:
  • [By Ethan Ryder]

    Allegiance Bancshares (NASDAQ:ABTX)’s share price hit a new 52-week high and low during mid-day trading on Friday . The company traded as low as $42.80 and last traded at $41.40, with a volume of 51295 shares. The stock had previously closed at $40.75.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Allegiance Bancshares (ABTX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Stocks To Buy For 2019: Nortek Inc.(NTK)

Advisors' Opinion:
  • [By Stephan Byrd]

    News articles about Nortek (NASDAQ:NTK) have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Nortek earned a coverage optimism score of 0.21 on Accern’s scale. Accern also gave media stories about the construction company an impact score of 47.207131440996 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Stephan Byrd]

    NetKoin (NTK) is a token. Its genesis date was January 7th, 2018. NetKoin’s total supply is 99,508,709,867 tokens. The official website for NetKoin is www.netkoin.com. NetKoin’s official Twitter account is @netkoin and its Facebook page is accessible here.

  • [By Logan Wallace]

    Neurotoken (CURRENCY:NTK) traded down 8.5% against the dollar during the 1 day period ending at 22:00 PM Eastern on September 2nd. One Neurotoken token can currently be purchased for approximately $0.0421 or 0.00000579 BTC on cryptocurrency exchanges including BCEX, YoBit, Tidex and Cobinhood. In the last seven days, Neurotoken has traded 17.7% lower against the dollar. Neurotoken has a total market capitalization of $3.41 million and approximately $211,773.00 worth of Neurotoken was traded on exchanges in the last day.

Top 5 Stocks To Buy For 2019: Vaalco Energy Inc(EGY)

Advisors' Opinion:
  • [By Money Morning Staff Reports]

    But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we'll show you a small-cap stock with great profit potential in its future…

    Penny Stock Current Share Price Law Month's Gain  Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85% Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40% Vivis Inc. (Nasdaq: VVUS) $0.77 150.41% Adomani Inc. (Nasdaq: ADOM) $1.49 137.68% NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88% Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06% Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12% ArQule Inc. (Nasdaq: ARQL) $4.88 90.74% LiqTech International Inc. (NYSE: LIQT) $0.66 85.60% Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

    While last month's gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

  • [By Joseph Griffin]

    VAALCO Energy, Inc. (NYSE:EGY)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $2.53, but opened at $2.59. VAALCO Energy shares last traded at $2.75, with a volume of 2086739 shares trading hands.

  • [By Lisa Levin] Gainers Cara Therapeutics, Inc. (NASDAQ: CARA) rose 18.2 percent to $13.71 in pre-market trading. Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma entered into ex-U.S. licensing agreement to commercialize KORSUVA™ injection in dialysis patients with pruritus. Heat Biologics, Inc. (NASDAQ: HTBX) shares rose 10.6 percent to $2.20 in pre-market trading after surging 12.43 percent on Tuesday. VAALCO Energy, Inc. (NYSE: EGY) rose 10.5 percent to $2.37 in pre-market trading after dropping 10.04 percent on Tuesday. Boxlight Corporation (NASDAQ: BOXL) rose 8.3 percent to $7.15 in pre-market trading after falling 16.03 percent on Tuesday. Tiffany & Co. (NYSE: TIF) rose 7.8 percent to $110.25 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY2018 earnings guidance. Heat Biologics, Inc. (NASDAQ: HTBX) shares rose 7.1 percent to $2.13 in pre-market trading. after climbing 12.43 percent on Tuesday. Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) rose 5.9 percent to $20.01 in pre-market trading after reporting positive Phase 2 Part B data showing treatment with palovarotene significantly reduces new bone growth in patients with FOP. Under Armour, Inc. (NYSE: UA) rose 3.5 percent to $18.44 in pre-market trading. Aegean Marine Petroleum Network Inc. (NYSE: ANW) shares rose 3.5 percent to $2.95 in pre-market trading. MetLife, Inc. (NYSE: MET) rose 3.2 percent to $50.00 in pre-market trading after reporting a $1.5 billion buyback plan. Lowe's Companies, Inc. (NYSE: LOW) rose 3.2 percent to $88.51 in pre-market trading. Lowe's reported downbeat results for its first quarter on Wednesday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers Cara Therapeutics, Inc. (NASDAQ: CARA) shares surged 42.76 percent to close at $16.56 on Wednesday in reaction to a new licensing agreement with Europe-based Vifor Pharma. As part of the agreement, the biopharmaceutical company that alleviates pain licensed worldwide rights (except U.S., Japan, and South Korea) to Vifor Pharma to commercialize its KORSUVA therapy to Vifor $70 million. Yangtze River Port and Logistics Limited (NASDAQ: YRIV) gained 31.28 percent to close at $7.05 on Wednesday. Tiffany & Co. (NYSE: TIF) climbed 23.29 percent to close at $126.05 after the company reported upbeat results for its first quarter and raised its FY2018 earnings guidance. EVO Payments, Inc. (NASDAQ: EVOP) gained 18.88 percent to close at $19.02. EVO Payments priced its IPO at $16 per share. Carver Bancorp, Inc. (NASDAQ: CARV) rose 16.1 percent to close at $6.85. USA Technologies, Inc. (NASDAQ: USAT) gained 15.68 percent to close at $13.65 after announcing pricing of public offering. eXp World Holdings, Inc. (NASDAQ: EXPI) shares jumped 15.01 percent to close at $17.70. Geron Corporation (NASDAQ: GERN) gained 14.99 percent to close at $4.68. Evolus, Inc. (NASDAQ: EOLS) rose 14.62 percent to close at $19.36. Ralph Lauren Corporation (NYSE: RL) shares rose 14.34 percent to close at $133.33 after the company reported stronger-than-expected results for its fourth quarter. Turtle Beach Corporation (NASDAQ: HEAR) jumped 13.26 percent to close at $17.34 on Wednesday. Turtle Beach S-3 showed registration for 1.857 million share common stock offering via selling holders. Communications Systems, Inc. (NASDAQ: JCS) rose 13.18 percent to close at $3.95. Communications Systems reported establishment of special committee to explore strategic alternatives. Immutep Limited (NASDAQ: IMMP) shares climbed 12.95 percent to close at $2.53. xG Technology, Inc. (NASDAQ: XGTI) rose 12.64 percent to close at $0.8561 after the company&rsq

Top 5 Stocks To Buy For 2019: Celyad SA(CYAD)

Advisors' Opinion:
  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering. Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET. XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday. Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results. Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday. RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday. Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering. Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading. Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements. Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results. CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering
  • [By Lisa Levin] Gainers Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8. Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica. DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance. eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results. Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results. SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results. Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results. Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36. Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday. ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial. Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70. Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday. Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
  • [By Lisa Levin]

    Breaking news

    Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis, Inc. (NASDAQ: ABAX) for $83 per share in cash. Boot Barn Holdings Inc (NYSE: BOOT) reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. CELYAD SA/ADR (NASDAQ: CYAD) reported launch of 1.8 million share offering. Verastem Inc (NASDAQ: VSTM) shares dropped 12 percent in pre-market trading after announcing a $35 million common stock offering.

  • [By Max Byerly]

    Shares of CELYAD SA/ADR (NASDAQ:CYAD) have been assigned a consensus recommendation of “Buy” from the six analysts that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $53.00.

Top 5 Stocks To Buy For 2019: KMG Chemicals, Inc.(KMG)

Advisors' Opinion:
  • [By Shane Hupp]

    KMG Chemicals (NYSE:KMG) released its quarterly earnings data on Monday. The specialty chemicals company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of $0.98 by $0.28, MarketWatch Earnings reports. The firm had revenue of $122.39 million for the quarter, compared to the consensus estimate of $121.10 million. KMG Chemicals had a net margin of 11.87% and a return on equity of 16.21%.

  • [By Joseph Griffin]

    Brown Advisory Inc. increased its stake in KMG Chemicals, Inc. (NYSE:KMG) by 37.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 176,895 shares of the specialty chemicals company’s stock after acquiring an additional 48,374 shares during the period. Brown Advisory Inc.’s holdings in KMG Chemicals were worth $13,051,000 at the end of the most recent reporting period.

  • [By Motley Fool Staff]

    KMG Chemicals (NYSE:KMG) Q3 2018 Earnings Conference CallJun. 11, 2018 5:00 p.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Morgan Dempsey Capital Management LLC lowered its stake in KMG Chemicals, Inc. (NYSE:KMG) by 57.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,424 shares of the specialty chemicals company’s stock after selling 20,490 shares during the period. Morgan Dempsey Capital Management LLC owned 0.10% of KMG Chemicals worth $925,000 at the end of the most recent quarter.

Monday, February 18, 2019

Zacks: Analysts Expect Cypress Semiconductor Co. (CY) Will Announce Earnings of $0.24 Per Share

Wall Street brokerages expect that Cypress Semiconductor Co. (NASDAQ:CY) will report $0.24 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for Cypress Semiconductor’s earnings. Cypress Semiconductor posted earnings of $0.27 per share in the same quarter last year, which would indicate a negative year over year growth rate of 11.1%. The business is scheduled to announce its next earnings results on Thursday, April 25th.

According to Zacks, analysts expect that Cypress Semiconductor will report full year earnings of $1.09 per share for the current year, with EPS estimates ranging from $1.05 to $1.13. For the next financial year, analysts expect that the firm will post earnings of $1.22 per share, with EPS estimates ranging from $1.17 to $1.38. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side research firms that follow Cypress Semiconductor.

Get Cypress Semiconductor alerts:

Cypress Semiconductor (NASDAQ:CY) last posted its quarterly earnings data on Thursday, January 31st. The semiconductor company reported $0.30 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.27 by $0.03. Cypress Semiconductor had a return on equity of 22.01% and a net margin of 14.28%. The company had revenue of $604.47 million during the quarter, compared to analyst estimates of $598.72 million.

A number of research analysts recently weighed in on the company. Piper Jaffray Companies set a $15.00 price objective on Cypress Semiconductor and gave the company a “buy” rating in a research report on Friday, October 26th. BidaskClub lowered Cypress Semiconductor from a “buy” rating to a “hold” rating in a report on Saturday, December 1st. ValuEngine lowered Cypress Semiconductor from a “sell” rating to a “strong sell” rating in a report on Wednesday, October 24th. Craig Hallum cut their price objective on Cypress Semiconductor from $25.00 to $20.00 and set a “buy” rating for the company in a report on Friday, October 26th. Finally, Zacks Investment Research lowered Cypress Semiconductor from a “hold” rating to a “sell” rating in a report on Monday, December 31st. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and eight have given a buy rating to the company’s stock. Cypress Semiconductor currently has an average rating of “Hold” and an average target price of $17.45.

In related news, EVP Sudhir Gopalswamy sold 12,598 shares of Cypress Semiconductor stock in a transaction on Friday, January 25th. The stock was sold at an average price of $14.00, for a total transaction of $176,372.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Hassane El-Khoury sold 4,300 shares of Cypress Semiconductor stock in a transaction on Wednesday, January 9th. The shares were sold at an average price of $13.00, for a total value of $55,900.00. The disclosure for this sale can be found here. Insiders have sold 66,898 shares of company stock worth $926,272 over the last quarter. 0.43% of the stock is owned by company insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CY. Vanguard Group Inc. lifted its position in shares of Cypress Semiconductor by 8.2% in the third quarter. Vanguard Group Inc. now owns 37,219,787 shares of the semiconductor company’s stock valued at $539,316,000 after acquiring an additional 2,820,094 shares in the last quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp purchased a new position in shares of Cypress Semiconductor in the third quarter valued at about $5,458,000. The Manufacturers Life Insurance Company lifted its position in shares of Cypress Semiconductor by 3.3% in the third quarter. The Manufacturers Life Insurance Company now owns 598,602 shares of the semiconductor company’s stock valued at $8,674,000 after acquiring an additional 19,087 shares in the last quarter. Martingale Asset Management L P purchased a new position in shares of Cypress Semiconductor in the third quarter valued at about $2,752,000. Finally, Cambridge Investment Research Advisors Inc. lifted its position in shares of Cypress Semiconductor by 22.9% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 81,866 shares of the semiconductor company’s stock valued at $1,186,000 after acquiring an additional 15,252 shares in the last quarter. Institutional investors own 83.13% of the company’s stock.

CY stock traded down $0.03 on Friday, reaching $15.70. 2,871,095 shares of the company traded hands, compared to its average volume of 5,126,994. Cypress Semiconductor has a one year low of $11.75 and a one year high of $18.87. The company has a quick ratio of 0.89, a current ratio of 1.30 and a debt-to-equity ratio of 0.41. The firm has a market cap of $5.68 billion, a PE ratio of 13.53, a price-to-earnings-growth ratio of 1.83 and a beta of 1.85.

Cypress Semiconductor Company Profile

Cypress Semiconductor Corporation designs, develops, manufactures, markets, and sells embedded system solutions worldwide. It operates in two segments, Microcontroller and Connectivity Division, and Memory Products Division. The Microcontroller and Connectivity Division provides microcontroller (MCU), analog, and wireless and wired connectivity solutions, including Traveo automotive MCUs; programmable system-on-chip and general-purpose MCUs; ARM Cortex-M4, -M3, and -M0+ MCUs; R4 CPUs; analog power management integrated circuits and energy harvesting solutions; CapSense capacitive-sensing controllers; TrueTouch touchscreens; Wi-Fi, Bluetooth, Bluetooth low energy, and ZigBee solutions; WICED development platform; and USB controllers comprising solutions for the USB-C and USB power delivery standards, as well as wireless Internet of things connectivity solutions.

Featured Article: What is a stock buyback?

Get a free copy of the Zacks research report on Cypress Semiconductor (CY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Sunday, February 17, 2019

Top 5 Gold Stocks To Invest In Right Now

tags:NXG,CME,ORE,NGD,GSS,

With the S&P 500 not likely to do much the rest of the year, Goldman Sachs says there is still an investment strategy that can outperform.

The firm recommended companies with strong prospects for sales growth next year. David Kostin, Goldman's chief U.S. equity strategist, updated his "high revenue growth" stock basket, which is now based on 2019 Wall Street estimates.

He wrote in a note to clients Friday that with the rate of GDP growth expected to slow next year, "We continue to recommend investors own stocks with the highest forecast sales growth."

The basket includes several internet and technology stocks such as Amazon, Netflix and Autodesk.

Kostin reiterated his year-end price target of 2,850 for the S&P 500, representing just 4.5 percent upside from Friday's close.

Top 5 Gold Stocks To Invest In Right Now: Northgate Minerals Corporation(NXG)

Advisors' Opinion:
  • [By Shane Hupp]

    Shares of NEX Group PLC (LON:NXG) have been given an average rating of “Hold” by the nine ratings firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is GBX 696 ($9.21).

Top 5 Gold Stocks To Invest In Right Now: CME Group Inc.(CME)

Advisors' Opinion:
  • [By Logan Wallace]

    Investors sold shares of CME Group Inc (NASDAQ:CME) on strength during trading hours on Wednesday. $43.03 million flowed into the stock on the tick-up and $84.28 million flowed out of the stock on the tick-down, for a money net flow of $41.25 million out of the stock. Of all stocks tracked, CME Group had the 11th highest net out-flow for the day. CME Group traded up $0.26 for the day and closed at $170.48

  • [By Shane Hupp]

    Thrivent Financial for Lutherans increased its position in CME Group (NASDAQ:CME) by 2.7% during the first quarter, HoldingsChannel.com reports. The firm owned 14,201 shares of the financial services provider’s stock after buying an additional 377 shares during the quarter. Thrivent Financial for Lutherans’ holdings in CME Group were worth $2,297,000 as of its most recent filing with the SEC.

  • [By Lee Jackson]

    This stock has had a solid 2018 and is a top pick at Deutsche Bank. CME Group Inc. (NASDAQ: CME) exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options. CME brings buyers and sellers together through its Globex electronic trading platform and its trading facilities in New York and Chicago.

  • [By Motley Fool Staff]

    CME Group (NASDAQ:CME) Q1 2018 Earnings Conference CallApril 26, 2018 8:30 a.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

Top 5 Gold Stocks To Invest In Right Now: Orezone Gold Corp (ORE)

Advisors' Opinion:
  • [By Peter Graham]

    Sandstorm's due diligence is thorough, they don't just invest in any company. They like West Africa because they understand the area and the opportunities that exist there. Sandstorm is a royalty and streaming company, so they make these investments and receive cashflow deals that often kick in much later on. But they have already established a presence in Burkina and have deals in place with larger companies like Orezone Gold (TSXV: ORE) and Endeavour Mining (TSX: EDV). Sandstorm's investment also potentially gives us access to their marketing department through something they call Launch Lab, and it looks like it will really benefit our own marketing efforts and will expose us to more opportunities over the coming year.

  • [By Jim Robertson]

    Finally, Richard Seville, the CEO of Brisbane-based Orocobre Ltd (ASX: ORE) which began lithium sales in 2015 from northern Argentina and also experienced difficulty boosting output, commented that an "inability to access traditional funds has delayed the development of the sector" and that "these projects aren't easy -- so the banks just don't want to go there."

  • [By Shane Hupp]

    Galactrum (ORE) is a PoW/PoS coin that uses the
    Lyra2RE hashing algorithm. It was first traded on December 13th, 2017. Galactrum’s total supply is 2,781,952 coins and its circulating supply is 2,061,952 coins. Galactrum’s official website is galactrum.org. Galactrum’s official Twitter account is @galactrum.

  • [By Stephan Byrd]

    Galactrum (CURRENCY:ORE) traded 1.7% lower against the U.S. dollar during the 24 hour period ending at 18:00 PM Eastern on August 31st. Galactrum has a total market capitalization of $866,847.00 and approximately $5,272.00 worth of Galactrum was traded on exchanges in the last 24 hours. One Galactrum coin can now be purchased for about $0.42 or 0.00006032 BTC on major exchanges including Stocks.Exchange and Cryptopia. In the last seven days, Galactrum has traded 12.5% higher against the U.S. dollar.

Top 5 Gold Stocks To Invest In Right Now: NEW GOLD INC.(NGD)

Advisors' Opinion:
  • [By Lisa Levin] Gainers ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share. Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook. vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June. Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results. RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results. Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million. Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter. Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales. Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings. MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma. New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor. Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session. Himax Technologies, Inc. (NASDAQ: HIMX) shares rose
  • [By Stephan Byrd]

    JPMorgan Chase & Co. downgraded shares of New Gold (NYSEAMERICAN:NGD) from a neutral rating to an underweight rating in a research report released on Wednesday, The Fly reports.

  • [By Matthew DiLallo]

    Shares of New Gold (NYSEMKT:NGD) sold off on Thursday, plunging more than 20% by 11 a.m. EST after the gold mining company reported its fourth-quarter results as well as its outlook for 2019.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers Teradyne, Inc. (NYSE: TER) fell 10.8 percent to $37.02 in pre-market trading after the company issued downbeat Q2 guidance. Edwards Lifesciences Corporation (NYSE: EW) fell 9.2 percent to $122.29 in pre-market trading. Edwards Lifesciences reported better-than-expected results for its first quarter, but issued weak earnings guidance for the second quarter. New Gold Inc. (NYSE: NGD) fell 8.8 percent to $2.30 in pre-market trading after rising 4.13 percent on Tuesday. Gold Fields Limited (ADR) (NYSE: GFI) fell 8.6 percent to $3.61 in pre-market trading. Natus Medical Incorporated (NASDAQ: BABY) fell 8.2 percent to $32.95 in pre-market trading after the company issued weak forecast for the second quarter. Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 7.9 percent to $3.50 in pre-market trading after climbing 27.09 percent on Tuesday. Bright Scholar Education Holdings Limited (NYSE: BEDU) shares fell 6.7 percent to $13.58 in pre-market trading after reporting Q1 results. Sangamo Therapeutics Inc (NASDAQ: SGMO) fell 5.9 percent to $16.75 in pre-market trading following announcement of a $200 million common stock offering. Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) shares fell 5.7 percent to $3.29 in pre-market trading after declining 3.32 percent on Tuesday. Euronav NV (NYSE: EURN) fell 4.8 percent to $8.40 in pre-market trading. Limelight Networks, Inc. (NASDAQ: LLNW) shares fell 4.3 percent to $4.69 in pre-market trading. Gaming and Leisure Properties Inc (NASDAQ: GLPI) shares fell 4.1 percent to $32.92 in pre-market trading after the company issued downbeat quarterly results and reported the retirement of CFO William Clifford
  • [By Paul Ausick]

    New Gold Inc. (NYSEAMERICAN: NGD) dropped about 1.9% Tuesday to post a new 52-week low of $2.09. Shares closed at $2.13 on Monday and the stock’s 52-week high is $4.25. The junior gold miner had no specific news.

  • [By Maxx Chatsko]

    Shares of New Gold (NYSEMKT:NGD) fell by over 14% today after the company announced the surprise sale of its Mesquite gold mine. The business will receive $158 million in cash for the productive asset, which management says will "immediately crystallize several years' worth of future free cash flow as part of our strategy to prudently manage our balance sheet, providing the company with the financial flexibility to focus on our core assets".

Top 5 Gold Stocks To Invest In Right Now: Golden Star Resources Ltd(GSS)

Advisors' Opinion:
  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Golden Star Resources (GSS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Golden Star Resources (GSS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Golden Star Resources (GSS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Golden Star Resources Ltd. (NYSEAMERICAN:GSS) was the target of a significant increase in short interest in September. As of September 28th, there was short interest totalling 10,021,831 shares, an increase of 6.9% from the September 14th total of 9,371,344 shares. Based on an average trading volume of 1,038,207 shares, the short-interest ratio is presently 9.7 days. Approximately 4.7% of the company’s shares are sold short.

  • [By Joseph Griffin]

    Golden Star Resources Ltd. (TSE:GSC) (NYSE:GSS) has been given an average recommendation of “Buy” by the six ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is C$1.48.